Business

Wegovy maker Novo Nordisk sues rival over ‘knock-off’ weight-loss drugs

Published

on

Novo Nordisk referenced the FDA’s concerns in its lawsuit announcement on Monday, saying Hims & Hers’ compounded drugs “may contain dangerous impurities or incorrect amounts of active ingredients, which can result in life-threatening immune responses”.

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Trending

Exit mobile version